Technical Analysis for PYPD - PolyPid Ltd.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 5.00 | 4.78% | 0.23 |
PYPD closed up 4.78 percent on Wednesday, May 1, 2024, on 3.4 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 8
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 50 DMA | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Stochastic Reached Overbought | Strength | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
NR7 | Range Contraction | 4.78% | |
Narrow Range Bar | Range Contraction | 4.78% |
Alert | Time |
---|---|
50 DMA Resistance | about 3 hours ago |
50 DMA Support | about 4 hours ago |
3x Volume Pace | about 4 hours ago |
Possible Pocket Pivot | about 4 hours ago |
Rose Above Previous Day's High | about 5 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Surgery Bone Infection Phosphates Antibiotics Lipid Polyp Incision Bone Grafting Surgical Site
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Surgery Bone Infection Phosphates Antibiotics Lipid Polyp Incision Bone Grafting Surgical Site
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.23 |
52 Week Low | 3.601 |
Average Volume | 2,568 |
200-Day Moving Average | 6.14 |
50-Day Moving Average | 4.98 |
20-Day Moving Average | 4.57 |
10-Day Moving Average | 4.63 |
Average True Range | 0.21 |
RSI (14) | 57.45 |
ADX | 14.4 |
+DI | 34.66 |
-DI | 27.28 |
Chandelier Exit (Long, 3 ATRs) | 4.45 |
Chandelier Exit (Short, 3 ATRs) | 4.84 |
Upper Bollinger Bands | 4.95 |
Lower Bollinger Band | 4.20 |
Percent B (%b) | 1.07 |
BandWidth | 16.48 |
MACD Line | -0.05 |
MACD Signal Line | -0.14 |
MACD Histogram | 0.0902 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.43 | ||||
Resistance 3 (R3) | 5.42 | 5.25 | 5.36 | ||
Resistance 2 (R2) | 5.25 | 5.14 | 5.26 | 5.34 | |
Resistance 1 (R1) | 5.13 | 5.07 | 5.04 | 5.14 | 5.31 |
Pivot Point | 4.96 | 4.96 | 4.92 | 4.97 | 4.96 |
Support 1 (S1) | 4.84 | 4.85 | 4.76 | 4.86 | 4.69 |
Support 2 (S2) | 4.67 | 4.78 | 4.68 | 4.66 | |
Support 3 (S3) | 4.55 | 4.67 | 4.64 | ||
Support 4 (S4) | 4.57 |